These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 24485040

  • 1. High ALDH1A1 expression correlates with poor survival in papillary thyroid carcinoma.
    Xing Y, Luo DY, Long MY, Zeng SL, Li HH.
    World J Surg Oncol; 2014 Feb 03; 12():29. PubMed ID: 24485040
    [Abstract] [Full Text] [Related]

  • 2. Thyroid cancer in Egypt: histopathological criteria, correlation with survival and oestrogen receptor protein expression.
    Ahmed RA, Aboelnaga EM.
    Pathol Oncol Res; 2015 Jul 03; 21(3):793-802. PubMed ID: 25576212
    [Abstract] [Full Text] [Related]

  • 3. [High aldehyde dehydrogenase 1A1 (ALDH1A1) expression correlated with risk of lymph node metastasis in papillary thyroid carcinoma].
    Yue C, Zhao X, Tian C, Jin Y, Liu H.
    Zhonghua Bing Li Xue Za Zhi; 2015 Jul 03; 44(7):490-4. PubMed ID: 26705040
    [Abstract] [Full Text] [Related]

  • 4. Associations of carboxypeptidase 4 with ALDH1A1 expression and their prognostic value in esophageal squamous cell carcinoma.
    Sun L, Cao J, Guo C, Burnett J, Yang Z, Ran Y, Sun D.
    Dis Esophagus; 2017 Jun 01; 30(6):1-5. PubMed ID: 28475748
    [Abstract] [Full Text] [Related]

  • 5. Up-regulation of nuclear receptor coactivator amplified in breast cancer-1 in papillary thyroid carcinoma correlates with lymph node metastasis.
    Liu MY, Guo HP, Hong CQ, Peng HW, Yang XH, Zhang H.
    Clin Transl Oncol; 2013 Nov 01; 15(11):947-52. PubMed ID: 23606350
    [Abstract] [Full Text] [Related]

  • 6. Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival.
    Akslen LA, Varhaug JE.
    Cancer; 1995 Nov 01; 76(9):1643-54. PubMed ID: 8635070
    [Abstract] [Full Text] [Related]

  • 7. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N, Dauzier E, Godiris-Petit G, Noullet S, Brocheriou I, Leenhardt L, Buffet C, Menegaux F.
    Langenbecks Arch Surg; 2018 May 01; 403(3):325-332. PubMed ID: 29445865
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Expression of ki67 in papillary thyroid microcarcinoma and its clinical significance.
    Zhou Y, Jiang HG, Lu N, Lu BH, Chen ZH.
    Asian Pac J Cancer Prev; 2015 May 01; 16(4):1605-8. PubMed ID: 25743839
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Increased expression of ALDH1A1 protein is associated with poor prognosis in clear cell renal cell carcinoma.
    Wang K, Chen X, Zhan Y, Jiang W, Liu X, Wang X, Wu B.
    Med Oncol; 2013 May 01; 30(2):574. PubMed ID: 23585015
    [Abstract] [Full Text] [Related]

  • 13. ALDH1A1 overexpression is associated with the progression and prognosis in gastric cancer.
    Li XS, Xu Q, Fu XY, Luo WS.
    BMC Cancer; 2014 Sep 24; 14():705. PubMed ID: 25253129
    [Abstract] [Full Text] [Related]

  • 14. The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer.
    Alamgeer M, Ganju V, Szczepny A, Russell PA, Prodanovic Z, Kumar B, Wainer Z, Brown T, Schneider-Kolsky M, Conron M, Wright G, Watkins DN.
    Thorax; 2013 Dec 24; 68(12):1095-104. PubMed ID: 23878161
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Improvement of lymph node recurrence rate, but not distant recurrence and carcinoma death rates, in patients with papillary thyroid carcinoma after disease-free survival for 5 years.
    Ito Y, Kudo T, Kihara M, Takamura Y, Kobayashi K, Miya A, Miyauchi A.
    Endocr J; 2012 Dec 24; 59(10):895-901. PubMed ID: 22785260
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dynamin 2 Is Correlated with Recurrence and Poor Prognosis of Papillary Thyroid Cancer.
    Ren N, Tian Z, Sun H, Lu X.
    Med Sci Monit; 2020 Aug 22; 26():e924590. PubMed ID: 32827429
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of serum DKK-1 predicts poor prognosis in patients with papillary thyroid cancer.
    Zhao YP, Wang W, Wang XH, Xu Y, Wang Y, Dong ZF, Zhang JJ.
    Genet Mol Res; 2015 Dec 29; 14(4):18886-94. PubMed ID: 26782539
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.